Lyumjev ® (insulin lispro)

För fullständig produktresumé för Lyumjev se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Kan patienter som behandlas med Lyumjev® ▼ (insulin lispro) vaccineras mot COVID-19?

Användning av vacciner mot SARS-CoV-2 hos patienter som behandlats med Lyumjev har inte studerats.

SE_cFAQ_URI085_USE_WITH_COVID-19_VACCINE
cFAQ
cFAQ
SE_cFAQ_URI085_USE_WITH_COVID-19_VACCINE
en-GB

Administration of COVID-19 Vaccines to Patients Receiving Lyumjev

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that has caused the recent COVID-19 pandemic (coronavirus disease 2019, COVID). Recently, vaccines have been developed against SARS-CoV-2 and additional vaccines are expected to be available in the coming months.1-3

SARS-CoV-2 Vaccination With Lyumjev

The use of a SARS-CoV-2 vaccine in patients treated with Lyumjev has not been studied by Eli Lilly and Company.

Decisions regarding the use of any vaccination, including SARS-CoV-2 vaccines, in patients treated with Lyumjev should be made at the discretion of the prescribing physician using their best clinical judgment, and must be made by the clinician after careful consideration of risk factors of the patient as well as the risks and benefits of vaccination.

Possible impact of vaccination on blood glucose concentration

The International Diabetes Federation IDF states that after any vaccination the blood glucose levels might rise for a few days.4

Further resources on COVID-19 Vaccines and Diabetes

For information on COVID-19 vaccines and diabetes, please refer to

For current information on COVID-19 and COVID-19 vaccines in gereral, please refer to the website of

References

1Dong Y, Dai T, Wei Y, et al. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):237. https://doi.org/10.1038/s41392-020-00352-y

2Jackson LA, Anderson EJ, Rouphael NG, et al; mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2 — preliminary report. N Engl J Med. 2020;383(20):1920-1931. https://doi.org/10.1056/NEJMoa2022483

3COVID-19 vaccines. Centers for Disease Control and Prevention. Updated December 31, 2020. Accessed January 4, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html

4International Diabetes Federation Europe. Diabetes & Coronavirus Vaccination. https://idf.org/our-network/regions-members/europe/europe-news/370-diabetes-coronavirus-vaccination.html. Accessed April 29, 2021

5Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19

6COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china

Datum fӧr senaste ӧversyn 2021 M01 04


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Klicka för att chatta är tillgänglig

Klicka för att chatta är offline

Skriv din fråga till oss